https://www.selleckchem.com/products/sr-717.html
7months with a delay of1month from the referral, 3.3months with a delay of 1 to 2months, and 5.0months with a delay of 2months (P= .002). In group A, recurrent ulcers were recorded for 11 patients (7.7%). In group B, recurrent ulcers were recorded for 12 patients (11.8%; P= .281). The results of the present retrospective comparative study support first-visit foam sclerotherapy as an effective method to initiate endovenous ablation to promote venous ulcer healing. In venous ulcers, delays to endovenous ablation should be avoided w
Like
Comment
Share
